With this addition, Fortis’ Delhi-NCR network grows to approx.2,000 beds, enabling expanded reach and stronger synergies Fortis Healthcare Limited today announced that its wholly owned subsidiary, International Hospital Limited (IHL), has entered into a 15-year lease agreement with RR Lifesciences Limited for a ~200-bed fully operational
Fortis Healthcare Ltd has reported a robust 57% jump in net profit, reaching ₹260 crore for the first quarter (Q1) of the fiscal year 2025, compared to ₹166 crore in the same period last year. The impressive performance reflects the company's strong operational efficiencies and
Two recently published clinical studies done by Fortis C-DOC hospital for Diabetes and Allied Sciences, New Delhi with the National Diabetes, Obesity and Cholesterol Foundation (N-DOC) in New Delhi revealed how a monitored consumption of a variety of Indian mangoes within restrictive diets may offer
Important Lessons for Indian Youth to Resist Narrative of E-Cigarette Manufacturers Studies by UC San Diego, University of Auckland and University of Sydney exposes e-cigarette companies E-cigarette companies’ claims about vaping displacing smoking are false The belief that vaping will help in quitting smoking
- The chief guest at the event was Hon’ble Chief Minister of Delhi Smt. Rekha Gupta- Fortis Hospital Shalimar Bagh today organised an Equality Walkathon to mark International Women’s Day and promote gender equality. The walkathon started at around 7:00 AM and ended at around 9:00
Treatment for Bilateral Wilms Tumour Achieved - Only 16 Similar Cases Documented Worldwide- In a ground-breaking medical achievement, Doctors at Fortis Escorts, Okhla, have successfully performed India's first treatment of Bilateral Wilms Tumour (nephroblastoma), a rare and complex form of paediatric kidney cancer in a 6-year-old
In a ground-breaking move that promises to transform patient care across the nation, Agilus Diagnostics, India’s largest diagnostic company, proudly announces the launch of its Pharmacogenomics Testing Service. This innovative service empowers healthcare providers and patients with vital insights into how individual genetic profiles influence
The LANDMARK randomised controlled trial (RCT) for MYVAL THV, a pioneering medical device, has been published by The Lancet This trial proves India’s capability to set new standards in cardiovascular care, and revolutionises heart valve treatment worldwide. Meril Life Sciences, an India-based global medical device
ASSOCHAM CSR Council, under the ILLNESS TO WELLNESS initiative, hosted a panel discussion on the eve of World Thyroid Day titled ‘Thyroid Matters: In Health & Disease’ with the primary goal of increasing awareness about thyroid diseases and the need to encourage early treatment of
The initiative unveiled key insights on need for micronutrients, multivitamins, and their support in driving overall long-term health. Centrum, the World’s number 1 Multivitamin[1], launched their health initiative titled ‘Your Nutrition Matters’. Held in wake up of the upcoming World Nutrition Day on 28th May 2024,
